Barbara Farlow, Advisor to the deVeber Institute, is featured in the Canadian Medical Association Journal (CMAJ) article:
"I feel that the genetic testing ultimately determined her fate," says Farlow, who lives in Mississauga, Ontario. "She was treated as a syndrome. She wasn't treated as a child."
Toronto, Canada (October 31, 2008) - A new non-invasive blood test for Down Syndrome, as described this month in the Proceedings of the National Academy of Sciences, and calls from the Society of Obstetricians and Gynaecologists of Canada to increase genetic screening before birth demand public and professional scrutiny for the practice of prenatal diagnosis.
Is Canada ready for these new tests?